NICOLAS SANTAMARIA: Open Payments
NPI 1982334801 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,595 in 95 payments from 15 companies in 2025. Trend: 2023 $3,218 · 2024 $2,923 · 2025 $1,595
Food & beverage: $1,595
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $363 |
| ABBVIE INC. | 13 | $203 |
| Vanda Pharmaceuticals Inc. | 9 | $188 |
| Alkermes, Inc. | 8 | $162 |
| Janssen Pharmaceuticals, Inc | 10 | $155 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $53 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, INVEGA SUSTENNA, HETLIOZ, Auvelity, FANAPT, REXULTI.
Industry payments across FL — which companies pay providers there.
